🇺🇸 FDA
Patent

US 12290520

Methods of use of emulsion formulations of aprepitant

granted A61KA61K31/5377A61K31/573

Quick answer

US patent 12290520 (Methods of use of emulsion formulations of aprepitant) held by Heron Therapeutics, Inc. expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Heron Therapeutics, Inc.
Grant date
Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/5377, A61K31/573, A61K47/10, A61K47/12